SCHEMBL6616566

SCHEMBL6616566

Cc1ccc(-c2cnc3cc4cn[nH]c4cc3n2)cc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.57
▸ MAPK1 P28482 2/20 0.53
▸ KDR P35968 3/20 0.49
▸ FLT3 P36888 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ PDGFRB P09619 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ FGFR1 P11362 3/20 0.45
▸ HPGD P15428 1/20 0.43
▸ ROCK2 O75116 3/20 0.43
▸ PIM1 P11309 3/20 0.43
▸ GSK3B P49841 3/20 0.43
▸ AURKB Q96GD4 3/20 0.43
▸ TRPA1 O75762 1/20 0.42
▸ TGFBR1 P36897 1/20 0.41
▸ JAK2 O60674 2/20 0.40
▸ PAK4 O96013 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6617887 1.00 NPC1 (0.57) NPC1MAPK1KDRFLT3RAB9A
SCHEMBL6621230 0.86 MAPK1 (0.49) NPC1MAPK1KDRFLT3RAB9A
SCHEMBL6618612 0.86 MAPK1 (0.49) NPC1MAPK1KDRFLT3RAB9A
SCHEMBL6617130 0.83 BCHE (0.54) NPC1MAPK1KDRFLT3RAB9A
SCHEMBL6619870 0.83 BCHE (0.54) NPC1MAPK1KDRFLT3RAB9A
SCHEMBL6623309 0.81 MAPK1 (0.53) NPC1MAPK1KDRFLT3RAB9A
SCHEMBL6620107 0.81 MAPK1 (0.53) NPC1MAPK1KDRFLT3RAB9A
SCHEMBL6618374 0.81 MAP3K11 (0.55) NPC1MAPK1RAB9APDGFRBSMN1; SMN2
SCHEMBL6618763 0.81 MAP3K11 (0.55) NPC1MAPK1RAB9APDGFRBSMN1; SMN2
SCHEMBL8103281 0.80 FGFR1 (0.45) NPC1MAPK1KDRFLT3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 — — EP disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 — — WO disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 — — US disclosed
Send feedback